Watkin Phoebe Yang Acquires 1,000 Shares of GE HealthCare Technologies (NASDAQ:GEHC) Stock

Posted by Geri Gentry on May 11th, 2026

GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) Director Watkin Phoebe Yang purchased 1,000 shares of GE HealthCare Technologies stock in a transaction that occurred on Friday, May 8th. The stock was acquired at an average price of $63.01 per share, for a total transaction of $63,010.00. Following the transaction, the director directly owned 13,702 shares of the company’s stock, valued at $863,363.02. The trade was a 7.87% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC traded down $1.77 on Monday, reaching $61.70. The company’s stock had a trading volume of 6,070,956 shares, compared to its average volume of 5,890,973. The company has a 50-day simple moving average of $71.06 and a 200 day simple moving average of $77.15. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The company has a market cap of $28.07 billion, a P/E ratio of 14.76, a PEG ratio of 1.43 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same period in the previous year, the business posted $1.01 EPS. The firm’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is presently 3.35%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on GEHC shares. Rothschild & Co Redburn reduced their price objective on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. HSBC dropped their price objective on GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. Wells Fargo & Company decreased their target price on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research report on Thursday, April 30th. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their price target for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. Finally, Piper Sandler dropped their target price on shares of GE HealthCare Technologies from $88.00 to $74.00 in a research note on Thursday, April 30th. Eight equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $80.67.

View Our Latest Stock Analysis on GEHC

Hedge Funds Weigh In On GE HealthCare Technologies

A number of hedge funds and other institutional investors have recently modified their holdings of GEHC. Oslo Pensjonsforsikring AS bought a new stake in GE HealthCare Technologies during the 1st quarter valued at $197,000. Andra AP fonden purchased a new stake in shares of GE HealthCare Technologies during the 1st quarter worth $93,000. Cassaday & Co Wealth Management LLC bought a new stake in GE HealthCare Technologies during the first quarter valued at about $136,000. Basepoint Wealth LLC grew its stake in GE HealthCare Technologies by 1,030.4% in the first quarter. Basepoint Wealth LLC now owns 7,427 shares of the company’s stock valued at $529,000 after purchasing an additional 6,770 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in GE HealthCare Technologies by 2.0% in the first quarter. Dimensional Fund Advisors LP now owns 5,399,439 shares of the company’s stock worth $384,219,000 after purchasing an additional 105,995 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

About GE HealthCare Technologies

(Get Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.